Follow The Filings

EDIT Editas Medicine Inc.

Health Care, filed as EDITAS MEDICINE INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 3 Owners
  • Max 1.1%
  • $13M
  • 1 new 1 add 1 small

In 2026 Q2 Nathan Fischel opened a position in Editas Medicine, and James Silverman added.

Who owns this now

Largest portfolio weights among holders, up to 1.1% (James Silverman, Opaleye Management). Not free-float ownership.

  1. James Silverman Add 1.1%
  2. Nathan Fischel New 0.11%

Who owns EDIT

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management 1.1%, was 0.62% Add +100.4% 3,861,930 $13M History
Nathan Fischel, Dafna Capital Management 0.11% New 0.11% 170,470 $552K History
Murray Stahl, Horizon Kinetics Asset Management <0.01% Small trim −4.6% 27,680 $90K History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by EDIT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EDIT insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 14 sales to cover taxes.

Congress

No member of Congress reported trading EDIT in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 4.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $78.12M $32.31M $40.52M
Net income -$153.22M -$237.09M -$160.06M
Net margin * -196.1% -733.7% -395.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $340.83M $289.32M $163.9M
Total non-current assets * $158.32M $52.27M $22.64M
Total assets $499.15M $341.59M $186.53M
Total current liabilities $63.22M $77.22M $46.25M
Total non-current liabilities * $86.84M $130.09M $113M
Total equity $349.1M $134.27M $27.29M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$132.18M -$210.28M -$165.24M
Cash from investing -$3.73M $162.15M $138.67M
Cash from financing $118.04M $56.03M $40.47M
Net change in cash -$17.87M $7.89M $13.9M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.